Pratt Cb
Impact in
- Dermatology top 5%
- Chemotherapy-related skin toxicity
- Pathology and Forensic Medicine top 10%
- Chemotherapy-induced organ toxicity mitigation
Papers in
- Oncology 8
- Cancer Treatment and Pharmacology 3
- Co-authors
- Evans We (3 shared papers)Donald P. Pinkel (3 shared papers)Neil N. Senzer (2 shared papers)Gaston K. Rivera (3 shared papers)Sidnei Epelman (1 shared paper)Nigel Maxwell Jaffe (1 shared paper)Sally L. George (1 shared paper)Steven George (1 shared paper)
- Journals
- Blood (1 paper)PubMed (19 papers)
- Partner nations
- United States
In The Last Decade
Pratt Cb
20 papers receiving 485 citations
Peers
Comparison fields: 5 of 70
- Dermatology 101
- Pathology and Forensic Medicine 129
- Pulmonary and Respiratory Medicine 212
- Oncology 156
- Cardiology and Cardiovascular Medicine 112
Countries citing papers authored by Pratt Cb
This map shows the geographic impact of Pratt Cb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pratt Cb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pratt Cb more than expected).
Fields of papers citing papers by Pratt Cb
This network shows the impact of papers produced by Pratt Cb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pratt Cb. The network helps show where Pratt Cb may publish in the future.
Co-authors
The 16 scholars most cited alongside Pratt Cb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Coordinated treatment of childhood rhabdomyosarcoma with surgery, radiotherapy, and combination chemotherapy. | 1972 | 132 |
| 2 | Age-related adriamycin cardiotoxicity in children. | 1978 | 73 |
| 3 | Ifosfamide-induced subclinical tubular nephrotoxicity despite mesna. | 1987 | 62 |
| 4 | Recovery from toxicity associated with high-dose methotrexate: prognostic factors. | 1977 | 43 |
| 5 | Pharmacokinetic evaluation of cisplatin in children with malignant solid tumors: a phase II study. | 1982 | 35 |
| 6 | Phase I study of ICRF-187 in pediatric cancer patients and comparison of its pharmacokinetics in children and adults. | 1986 | 31 |
| 7 | Tetany: a complication of cis-dichlorodiammineplatinum(II) therapy. | 1979 | 27 |
| 8 | 1979 | 25 | |
| 9 | Combination chemotherapy for osteosarcoma. | 1978 | 22 |
| 10 | Bleomycin, cyclophosphamide, and dactinomycin in metastatic osteosarcoma: lack of tumor regression in previously treated patients. | 1987 | 21 |
| 11 | Chemotherapy of metastatic retinoblastoma. | 1962 | 17 |
| 12 | Combination therapy including vincristine (NSC-67574) for malignant solid tumors in children. | 1968 | 16 |
| 13 | Fatal congestive heart failure following mitoxantrone treatment in two children previously treated with doxorubicin and cisplatin. | 1983 | 11 |
| 14 | Coordinated treatment of childhood rhabdomyosarcoma. | 1975 | 9 |
| 15 | Recombinant human TNF-alpha stimulates the secretion of granulocyte colony-stimulating factor in vivo. | 1992 | 9 |
| 16 | Evaluation of a chemotherapeutic regimen for primary liver cancer in children. | 1978 | 6 |
| 17 | Cisplatin and doxorubicin for locally recurrent and metastatic childhood rhabdomyosarcoma. | 1984 | 6 |
| 18 | Ongoing clinical studies of ifosfamide for pediatric cancer in the United States. | 1996 | 5 |
| 19 | Phase I study of neocarzinostatin in children with cancer. | 1978 | 4 |
| 20 | Selected applications of methotrexate alone and in combination in osteosarcoma. | 1981 | 2 |
About Pratt Cb
Pratt Cb is a scholar working on Oncology, Pathology and Forensic Medicine, Cancer Research, Pulmonary and Respiratory Medicine and Neurology, having authored 20 papers that have together received 556 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (4 papers), Cancer therapeutics and mechanisms (4 papers), Cancer Treatment and Pharmacology (3 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers), Neuroblastoma Research and Treatments (2 papers), Acute Lymphoblastic Leukemia research (2 papers), Glioma Diagnosis and Treatment (2 papers) and Childhood Cancer Survivors' Quality of Life (2 papers). The work is most often cited by research in Dermatology (101 citations), Pathology and Forensic Medicine (129 citations), Pulmonary and Respiratory Medicine (212 citations), Oncology (156 citations) and Cardiology and Cardiovascular Medicine (112 citations). Pratt Cb has collaborated with scholars based in United States. Frequent co-authors include Evans We, Donald P. Pinkel, Neil N. Senzer, Gaston K. Rivera, Sidnei Epelman, Nigel Maxwell Jaffe, Sally L. George, Steven George, H. Omar Hustu and GV Dahl. Their work appears in journals such as Blood and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.